Phaseline

Targets › SNF2

SNF2: drug programs, companies and trials

1 program from 1 company in 2 trials: 1 Phase 4, 1 Phase 1; Gastroenterology.

Open in Phaseline: the race on SNF2, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Procter and GambleTest Stannous Fluoride Dentifrice
Stannous fluoride (0.454%) dentifrice for anti-gingivitis and plaque reduction
SNF2Phase 4Gingivitis–

Conditions

Gingivitis (2)

Modalities

small molecule (1)

Companies

Procter and Gamble (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.